Brief: Charmacy Pharmaceutical Posts HY Net Profit Attributable To Shareholders Of RMB45.6 Million
23/08/2018 15:49
Aug 23 (Reuters) - Charmacy Pharmaceutical Co Ltd 2289.HK :
* HY NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS OF PARENT
COMPANY
RMB45.6 MILLION, UP 6.34%
* HY OPERATING REVENUE RMB2.02 BILLION VERSUS RMB1.90
BILLION
Source text for Eikon: ID:nHKS78YwDT
Further company coverage: 2289.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Charmacy Pharmaceutical Co
See all newsBrief: Charmacy Pharmaceutical Sees Decrease In Net Profit Attributable By 45% For Year
Brief: Charmacy Pharmaceutical Says Yao Chuanglong Ceased To Be Chairman
Brief: Charmacy Pharmaceutical Posts FY Operating Revenue RMB4,175.28 Million
Brief: Charmacy Pharmaceutical Says Controlling Shareholder To Provide Loan Facility
Brief: Charmacy Pharmaceutical Says Applied For Trading Resumption From Feb 17